Precision medicine is accelerating, driven by scientific advances, new technologies, and changing market dynamics. At the same time, launches are becoming more complex, with new indications, a growing number of biomarker subpopulations, and diagnostics increasingly determining therapeutic success.
This Better Market Access webinar recording examines the key trends shaping precision medicine in 2026 and what they mean for pharma commercial and market access teams. We explore how innovations such as AI, digital pathology, and liquid biopsy are reshaping the market, and why early, cross-functional planning around diagnostics is becoming more and more critical.
Watch the webinar to learn more about:
- Innovation trends reshaping precision medicine
- Key market access trends influencing diagnostics-led therapies
- Implications for commercial and market access strategy
